ASUUY(ASUUY)
ASUUY
No analyst ratings available
No analyst price targets available for ASUUY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $919.84B | $1.03T | $1.16T |
| Low | $871.07B | $957.29B | $1.09T |
| High | $983.89B | $1.15T | $1.27T |
| EBITDA Avg | $61.22B | $68.35B | $77.38B |
| Low | $57.98B | $63.72B | $72.67B |
| High | $65.49B | $76.43B | $84.78B |
| EBIT Avg | $56.42B | $62.98B | $71.31B |
| Low | $53.43B | $58.72B | $66.97B |
| High | $60.35B | $70.43B | $78.12B |
| Net Income Avg | $44.83B | $49.00B | $50.04B |
| Low | $41.28B | $45.12B | $46.08B |
| High | $50.40B | $55.09B | $56.25B |
| EPS Avg | $278.89 | $304.82 | $311.27 |
| Low | $256.82 | $280.70 | $286.64 |
| High | $313.54 | $342.69 | $349.95 |
| Analysts (Rev / EPS) | 6 / 1 | 5 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $235.80B | $222.07B | $233.88B | $255.46B | $290.63B | $289.17B |
| Low | $222.56B | $209.60B | $220.75B | $241.11B | $274.32B | $272.94B |
| High | $264.16B | $248.78B | $262.01B | $286.18B | $325.59B | $323.96B |
| EBITDA Avg | $15.69B | $14.78B | $15.57B | $17.00B | $19.34B | $19.25B |
| Low | $14.81B | $13.95B | $14.69B | $16.05B | $18.26B | $18.17B |
| High | $17.58B | $16.56B | $17.44B | $19.05B | $21.67B | $21.56B |
| EBIT Avg | $14.46B | $13.62B | $14.35B | $15.67B | $17.83B | $17.74B |
| Low | $13.65B | $12.86B | $13.54B | $14.79B | $16.83B | $16.74B |
| High | $16.20B | $15.26B | $16.07B | $17.55B | $19.97B | $19.87B |
| Net Income Avg | $12.43B | $10.30B | $11.18B | $13.08B | $15.11B | $12.35B |
| Low | $11.53B | $9.55B | $10.36B | $12.12B | $14.01B | $11.45B |
| High | $14.38B | $11.91B | $12.93B | $15.12B | $17.48B | $14.29B |
| EPS Avg | $73.49 | $60.89 | $66.08 | $77.29 | $89.33 | $73.02 |
| Low | $68.13 | $56.44 | $61.26 | $71.65 | $82.81 | $67.69 |
| High | $84.98 | $70.41 | $76.42 | $89.38 | $103.30 | $84.44 |
| Analysts (Rev / EPS) | 6 / 1 | 5 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 3 / 1 |